Melatonin rhythms in renal transplant recipients with sleep–wake disturbances

References

• Altpeter ES, Roosli M, Battaglia M, Pfluger D, Minder CE, Abelin T. (2006). Effect of short-wave (6–22 MHz) magnetic fields on sleep quality and melatonin cycle in humans: The Schwarzenburg shut-down study. Bioelectromagnetics. 27:142–50.
   PubMed Web of Science ®Google Scholar
• Alvaro PK, Roberts RM, Harris JK. (2013). A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep. 36:1059–68.
   PubMed Web of Science ®Google Scholar
• Antonovsky A. (1993). The structure and properties of the sense of coherence scale. Soc Sci Med. 36:725–33.
   PubMed Web of Science ®Google Scholar
• Bojkowski CJ, Arendt J. (1990). Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects. Clin Endocrinol (Oxf). 33:435–44.
   PubMed Web of Science ®Google Scholar
• Burgess HJ, Fogg LF. (2008). Individual differences in the amount and timing of salivary melatonin secretion. PLoS One. 3:e3055.
   PubMed Web of Science ®Google Scholar
• Burkhalter H, Brunner DP, Wirz-Justice A, Cajochen C, Weaver T, Steiger J, Fehr T, Venzin RM, De Geest S. (2013). Self-reported sleep disturbances in renal transplant recipients. BMC Nephrol. 14:1–12.
   PubMed Web of Science ®Google Scholar
• Burkhalter H, Sereika SM, Engberg S, Wirz-Justice A, Steiger J, De Geest S. (2011). Validity of 2 sleep quality items to be used in a large cohort study of kidney transplant recipients. Prog Transpl. 21:27–35.
   PubMed Web of Science ®Google Scholar
• Burkhalter H, Wirz-Justice A, Cajochen C, Weaver TE, Steiger J, Fehr T, Venzin RM, De Geest S. (2014). Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non-adherence: A cross-sectional, multi-center study. Clin Transplant. 28:58–66.
   PubMed Web of Science ®Google Scholar
• Burkhalter H, Wirz-Justice A, Denhaerynck K, Fehr T, Steiger J, Venzin RM, Cajochen C, Weaver TE, De Geest S. (2015). The effect of bright light therapy on sleep and circadian rhythms in renal transplant recipients: A pilot randomized, multicentre wait-list controlled trial. Transpl Int. 28:59–70.
   PubMed Web of Science ®Google Scholar
• Cajochen C, Krauchi K, Wirz-Justice A. (2003). Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol. 15:432–37.
   PubMed Web of Science ®Google Scholar
• Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. (2011). Sleep duration predicts cardiovascular outcomes: A systematic review and meta-analysis of prospective studies. Eur Heart J. 32(12):1484–1492.
   Web of Science ®Google Scholar
• Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. (2010). Quantity and quality of sleep and incidence of type 2 diabetes: A systematic review and meta-analysis. Diabetes Care. 33:414–20.
   PubMed Web of Science ®Google Scholar
• Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, Stranges S, Miller MA. (2008). Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 31:619–26.
   PubMed Web of Science ®Google Scholar
• Danilenko KV, Verevkin EG, Antyufeev VS, Wirz-Justice A, Cajochen C. (2014). The hockey-stick method to estimate evening dim light melatonin onset (DLMO) in humans. Chronobiol Int. 31:349–55.
   PubMed Web of Science ®Google Scholar
• Emens JS, Yuhas K, Rough J, Kochar N, Peters D, Lewy AJ. (2009). Phase angle of entrainment in morning- and evening-types under naturalistic conditions. Chronobiol Int. 26:474–93.
   PubMed Web of Science ®Google Scholar
• Figueiro MG, Rea MS. (2010). The effects of red and blue lights on circadian variations in cortisol, alpha amylase, and melatonin. Int. J. Endocrinol. 2010:829351.
   Google Scholar
• Godin G, Shephard RJ. (1985). A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 10:141–46.
   PubMedGoogle Scholar
• Griefahn B, Brode P, Blaszkewicz M, Remer T. (2003). Melatonin production during childhood and adolescence: A longitudinal study on the excretion of urinary 6-hydroxymelatonin sulfate. J Pineal Res. 34:26–31.
   PubMed Web of Science ®Google Scholar
• Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, Herer P, Tzischinsky O, Lavie P. (1994). Sleep disorders and melatonin rhythms in elderly people. BMJ. 309:167.
   Google Scholar
• Hajak G, Rodenbeck A, Bandelow B, Friedrichs S, Huether G, Ruther E. (1996). Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects. Eur Neuropsychopharmacol. 6:149–53.
   PubMed Web of Science ®Google Scholar
• Hardeland R. (2012). Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. Sci World J. 2012:640389.
   Web of Science ®Google Scholar
• Hardeland R, Madrid JA, Tan DX, Reiter RJ. (2012). Melatonin, the circadian multioscillator system and health: The need for detailed analyses of peripheral melatonin signaling. J Pineal Res. 52:139–66.
   PubMed Web of Science ®Google Scholar
• Hartter S, Korhonen T, Lundgren S, Rane A, Tolonen A, Turpeinen M, Laine K. (2006). Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin. Basic Clin Pharmacol Toxicol. 99:300–04.
   PubMed Web of Science ®Google Scholar
• Hawkins WW, Speck E, Leonard VG. (1954). Variation of the hemoglobin level with age and sex. Blood. 9: 999–1007.
   PubMed Web of Science ®Google Scholar
• Hilli J, Korhonen T, Turpeinen M, Hokkanen J, Mattila S, Laine K. (2008). The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism. J Clin Pharmacol. 48:986–94.
   PubMed Web of Science ®Google Scholar
• Hrenak J, Paulis L, Repova K, Aziriova S, Nagtegaal EJ, Reiter RJ, Simko F. (2015). Melatonin and renal protection: Novel perspectives from animal experiments and human studies (review). Curr Pharm Des. 21:936–49.
   PubMed Web of Science ®Google Scholar
• Israni AK, Snyder JJ, Skeans MA, Peng Y, Maclean JR, Weinhandl ED, Kasiske BL, Investigators P. (2010). Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant. 10:338–53.
   PubMed Web of Science ®Google Scholar
• Janus N, Launay-Vacher V, Ferrero JM, Thariat J. (2012). Risk of cancer in patients following chronic dialysis and kidney graft. Bull Cancer. 99:285–93.
   PubMed Web of Science ®Google Scholar
• Jay CL, Dean PG, Helmick RA, Stegall MD. (2015). Reassessing preemptive kidney transplantation in the United States: Are we making progress? Transplantation. Epub ahead of print.
   Google Scholar
• Karabulut AB, Ara C. (2009). Melatonin ameliorates tacrolimus (FK-506)’s induced immunosupressive effect in rat liver. Transplant Proc. 41:1875–77.
   PubMed Web of Science ®Google Scholar
• Karasek M, Szuflet A, Chrzanowski W, Zylinska K, Swietoslawski J. (2005). Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol Lett. 26:653–6.
   PubMed Web of Science ®Google Scholar
• Keijzer H, Smits MG, Peeters T, Looman CW, Endenburg SC, Gunnewiek JM. (2011). Evaluation of salivary melatonin measurements for Dim Light Melatonin Onset calculations in patients with possible sleep-wake rhythm disorders. Clin Chim Acta. 412:1616–20.
   PubMed Web of Science ®Google Scholar
• Koch BC, Nagtegaal JE, Hagen EC, van der Westerlaken MM, Boringa JB, Kerkhof GA, Ter Wee PM. (2009). The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: A randomized, placebo-controlled, cross-over study (EMSCAP study). Br J Clin Pharmacol. 67:68–75.
   PubMed Web of Science ®Google Scholar
• Koch BC, van der Putten K, Van Someren EJ, Wielders JP, Ter Wee PM, Nagtegaal JE, Gaillard CA. (2010). Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study). Nephrology, Dialysis, Transplantation: Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc. 25:513–19.
   Google Scholar
• Kräuchi K, Cajochen C, Pache M, Flammer J, Wirz-Justice A. (2006). Thermoregulatory effects of melatonin in relation to sleepiness. Chronobiol Int. 23:475–84.
   PubMed Web of Science ®Google Scholar
• Kunz D, Schmitz S, Mahlberg R, Mohr A, Stoter C, Wolf KJ, Herrmann WM. (1999). A new concept for melatonin deficit: On pineal calcification and melatonin excretion. Neuropsychopharmacol. 21:765–72.
   PubMed Web of Science ®Google Scholar
• Lewy AJ, Lefler BJ, Emens JS, Bauer VK. (2006). The circadian basis of winter depression. Proc Natl Acad Sci U S A. 103:7414–19.
   PubMed Web of Science ®Google Scholar
• Lewy AJ, Sack RL. (1989). The dim light melatonin onset as a marker for circadian phase position. Chronobiol Int. 6:93–102.
   PubMed Web of Science ®Google Scholar
• Lodhi SA, Lamb KE, Meier-Kriesche HU. (2011). Solid organ allograft survival improvement in the United States: The long-term does not mirror the dramatic short-term success. Am J Transplant. 11:1226–35.
   PubMed Web of Science ®Google Scholar
• Macchi MM, Bruce JN. (2004). Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol. 25:177–95.
   PubMed Web of Science ®Google Scholar
• Mahlberg R, Kienast T, Hadel S, Heidenreich JO, Schmitz S, Kunz D. (2009). Degree of pineal calcification (DOC) is associated with polysomnographic sleep measures in primary insomnia patients. Sleep Medicine. 10:439–45.
   PubMed Web of Science ®Google Scholar
• McIntyre IM, Burrows GD, Norman TR. (1988). Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans. Biol Psychiatry. 24:108–12.
   PubMed Web of Science ®Google Scholar
• McIntyre IM, Norman TR, Burrows GD, Armstrong SM. (1993). Alterations to plasma melatonin and cortisol after evening alprazolam administration in humans. Chronobiol Int. 10:205–13.
   PubMed Web of Science ®Google Scholar
• Miller E, Morel A, Saso L, Saluk J. (2015). Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders. Curr Top Med Chem. 15:163–69.
   PubMed Web of Science ®Google Scholar
• Mix TC, Kazmi W, Khan S, Ruthazer R, Rohrer R, Pereira BJ, Kausz AT. (2003). Anemia: A continuing problem following kidney transplantation. Am J Transplant. 3:1426–33.
   PubMed Web of Science ®Google Scholar
• Moe SM, Chen NX. (2008). Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol. 19:213–6.
   PubMed Web of Science ®Google Scholar
• Murphy PJ, Myers BL, Badia P. (1996). Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav. 59:133–9.
   PubMedGoogle Scholar
• Nafar M, Sahraei Z, Salamzadeh J, Samavat S, Vaziri ND. (2011). Oxidative stress in kidney transplantation: Causes, consequences, and potential treatment. Iran J Kidney Dis. 5:357–72.
   PubMed Web of Science ®Google Scholar
• Nagorny C, Lyssenko V. (2012). Tired of diabetes genetics? Circadian rhythms and diabetes: The MTNR1B story? Curr Diab Rep. 12:667–72.
   PubMed Web of Science ®Google Scholar
• Nagtegaal JE, Kerkhof GA, Smits MG, Swart AC, Van Der Meer YG. (1998). Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. J Sleep Res. 7:135–43.
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DP. (2005). Melatonin and sleep in aging population. Exp Gerontol. 40:911–25.
   PubMed Web of Science ®Google Scholar
• Parker KP. (2003). Sleep disturbances in dialysis patients. Sleep Med Rev. 7:131–43.
   PubMed Web of Science ®Google Scholar
• Pippias M, Stel VS, Areste-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Palsson R, Ravani P, Segelmark M, Traynor JP, Reisaeter AV, Caskey FJ, Jager KJ. (2015). Long-term kidney transplant outcomes in primary glomerulonephritis: Analysis from the ERA-EDTA registry. Transplantation. Epub ahead of print.
   Google Scholar
• Pullman RE, Roepke SE, Duffy JF. (2012). Laboratory validation of an in-home method for assessing circadian phase using dim light melatonin onset (DLMO). Sleep Medicine. 13:703–6.
   PubMed Web of Science ®Google Scholar
• Quiroz Y, Ferrebuz A, Romero F, Vaziri ND, Rodriguez-Iturbe B. (2008). Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am J Physiol Renal Physiol. 294:F336–44.
   PubMed Web of Science ®Google Scholar
• Remport A, Keszei A, Vamos EP, Novak M, Jaray J, Rosivall L, Mucsi I, Molnar MZ. (2011). Association of pre-transplant dialysis duration with outcome in kidney transplant recipients: A prevalent cohort study. Int Urol Nephrol. 43:215–24.
   PubMed Web of Science ®Google Scholar
• Rosenberger J, Geckova AM, Dijk JP, Roland R, Heuvel WJ, Groothof FJ. (2005). Factors modifying stress from adverse effects of immunosuppressive medication in kidney transplant recipients. Clin Transplant. 19:70–6.
   PubMed Web of Science ®Google Scholar
• Russcher M, Koch B, Nagtegaal E, van der Putten K, ter Wee P, Gaillard C. (2012). The role of melatonin treatment in chronic kidney disease. Front Biosci (Landmark Ed). 17:2644–56.
   Google Scholar
• Russcher M, Nagtegaal JE, Nurmohamed SA, Koch BC, van der Westerlaken MM, van Someren EJ, Bakker SJ, Ter Wee PM, Gaillard CA. (2015). The effects of kidney transplantation on sleep, melatonin, circadian rhythm and quality of life in kidney transplant recipients and living donors. Nephron. 129:6–15.
   PubMed Web of Science ®Google Scholar
• Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM. (1986). Human melatonin production decreases with age. J Pineal Res. 3:379–88.
   PubMed Web of Science ®Google Scholar
• Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J, Malhotra A, Shea SA. (2012). Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: A randomized controlled trial. Sleep. 35: 1395–1402.
   PubMed Web of Science ®Google Scholar
• Stepanski EJ, Wyatt JK. (2003). Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev. 7:215–25.
   PubMed Web of Science ®Google Scholar
• Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W. (1999). Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol. 55:111–5.
   PubMed Web of Science ®Google Scholar
• Stoschitzky K, Stoschitzky G, Brussee H, Bonelli C, Dobnig H. (2006). Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. Cardiology. 106:199–206.
   PubMed Web of Science ®Google Scholar
• Uchiyama M, Shibui K, Hayakawa T, Kamei Y, Ebisawa T, Tagaya H, Okawa M, Takahashi K. (2002). Larger phase angle between sleep propensity and melatonin rhythms in sighted humans with non-24-hour sleep-wake syndrome. Sleep. 25:83–88.
   PubMed Web of Science ®Google Scholar
• Van Thillo A, Devriendt K, Willekens D. (2010). Sleep disturbances in Smith-Magenis syndrome: Treatment with melatonin and beta-adrenergic antagonists. Tijdschr Psychiatr. 52:719–23.
   PubMedGoogle Scholar
• Vijayasarathy K, Shanthi Naidu K, Sastry BK. (2010). Melatonin metabolite 6-sulfatoxymelatonin, Cu/Zn superoxide dismutase, oxidized LDL and malondialdehyde in unstable angina. Int J Cardiol. 144:315–17.
   PubMed Web of Science ®Google Scholar
• Vitaterna MH, Takahashi JS, Turek FW. (2001). Overview of circadian rhythms. Alcohol Res Health: J National Inst Alcohol Abuse Alcoholism. 25:85–93.
   PubMed Web of Science ®Google Scholar
• Weber J, Schwander J, Unger I, Meier D. (1997). A direct ultrasensitive RIA for the determination of melatonin in human saliva: Comparison with serum levels. Sleep Res. 26:757.
   Google Scholar
• Wong G, Chapman JR. (2008). Cancers after renal transplantation. Transplant Rev. 22:141–9.
   Google Scholar
• Wyatt JK, Dijk DJ, Ritz-de Cecco A, Ronda JM, Czeisler CA. (2006). Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep. 29:609–18.
   PubMed Web of Science ®Google Scholar
• Zhou SF, Zhou ZW, Yang LP, Cai JP. (2009). Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 16:3480–675.
   PubMed Web of Science ®Google Scholar